retatrutide mechanism glp-1 gip glucagon triple agonist Glucagon-like peptide-1 receptor: mechanisms and advances in therapy What GLP‑3 Really Is: Retatrutide

Consequently, some authors consider GLP-1 RAs to be safe in the IBD population, however, they emphasise the necessity of providing educational advice to patients (e.g

Decreasing glucagon release

The eligibility criteria of the Novo Nordisk Patient Assistant Program (PAP) in 2025: You must have a valid prescription from a certified healthcare professional for an FDA-approved indication

(2006b)

[39] defined treatment (exenatide, lixisenatide, semaglutide, dulaglutide, liraglutide, tirzepatide, albiglutide) and control groups based on GLP-1 RA exposure: the treatment group included patients who initiated a GLP-1 RA within 6 months of IIH diagnosis, while the control group consisted of patients who never initiated a GLP-1 RA but were managed with conventional therapies such as acetazolamide, topiramate and furosemide

In mild cases, it can lead to symptoms like nausea, vomiting, bloating, and abdominal pain